News
Teleflex Announces Launch of its Next Generation Vascular Positioning System
May 20, 2013 5:00 pm | by The Associated Press | CommentsLIMERICK, Pa.--(BUSINESS WIRE)--May 20, 2013--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announces the launch of the ARROW ® VPS G4 ™ Device. The ARROW VPS G4 Device is used in conjunction with the disposable ARROW ® VPS ® Stylet....
Given Imaging Announces New European Study Evaluating PillCam(R) COLON versus CT-Colonography in Patients With Incomplete Colonoscopy
May 20, 2013 4:45 pm | by GlobeNewswire | CommentsGiven Imaging Ltd, a world leader in GI medical devices and pioneer of capsule endoscopy, today announced data from several European studies confirming the effectiveness of PillCam COLON in detecting colonic lesions in patients following incomplete colonoscopies and monitoring diverse digestive diseases in both adults and children.
B. Braun Committed To Improving Patient Safety
May 20, 2013 3:00 pm | by PR Newswire | CommentsBETHLEHEM, Pa., May 20, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) is committed to enhancing patient, clinician and environmental safety with products, services and education focused on sharing best clinical practices. B.Braun will feature its innovative Outlook® 400ES...
Commonly Used Catheters Double Risk of Blood Clots in ICU and Cancer Patients
May 20, 2013 11:32 am | by University of Michigan Health System | CommentsTouted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications. But compared to other central venous catheters, these commonly-used catheters more than double the risk of dangerous blood clots – especially among patients who are critically ill or who have cancer.
Study Finds that Sleep Apnea and Alzheimer's Are Linked
May 20, 2013 11:25 am | by American Thoracic Society | CommentsA new study looking at sleep-disordered breathing and markers for Alzheimer's disease risk in cerebrospinal fluid and neuroimaging adds to the growing body of research linking the two. But this latest study also poses an interesting question: Could AD in its "preclinical stages" also lead to SDB and explain the increased prevalence of SDB in the elderly?
ER Docs Are Key to Reducing Health Care Costs
May 20, 2013 11:22 am | by American College of Emergency Physicians | CommentsEmergency physicians are key decisionmakers for nearly half of all hospital admissions, highlighting a critical role they can play in reducing health care costs, according to a new report from the RAND Corporation. Hospital admissions from the ER increased by 17 percent over seven years, accounting for nearly all the growth in hospital admissions between 2003 and 2009.
Genetic Screening Could Reveal Hidden High Risk for Coronary Heart Disease
May 20, 2013 11:18 am | by University of Helsinki | CommentsThe study comprised over 24,000 Finnish subjects and was led by Professor Samuli Ripatti. The results revealed that a panel of 28 genetic markers improved detection of individuals with high risk for coronary heart disease (CHD) (10-year risk ≥20%) over traditional risk factors.
Wyle Aided System Gets Named to Space Technology Hall of Fame
May 20, 2013 11:15 am | by PR Newswire | CommentsEL SEGUNDO, Calif., May 20, 2013 /PRNewswire/ -- A medical diagnostic technology that experts at Wyle helped perfect for use both in space and on Earth was inducted recently in the Space Technology Hall of Fame. The technology assures high quality, secure handling and transmission of...
Covidien Receives FDA 510(k) Clearance for Nellcor Pulse Oximetry Motion Claims
May 20, 2013 11:11 am | by Covidien | CommentsCovidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that its Nellcor™ pulse oximetry portfolio, which is used to measure arterial oxygen saturation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for motion claims.
PENTAX Medical Continues Global Leadership in Endoscopic Ultrasound Systems with Release of the Hi Vision Preirus
May 20, 2013 11:08 am | by PENTAX Medical Company | CommentsPENTAX Medical Company, a healthcare industry leader in endoscopic imaging, recently announced the release of the HI VISION™ Preirus™ ultrasound scanner. PENTAX Medical, in collaboration with Hitachi-Aloka, has had a rich history of introducing ultrasound scanners to the gastroenterology and pulmonary markets that present new possibilities in imaging capabilities.
New Diagnostics Solutions from Welch Allyn to Help Improve Patient Safety, Reduce Risk for Facilities
May 20, 2013 11:05 am | by Welch Allyn | CommentsWelch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, will showcase its new FlexiPort® EcoCuffTM blood pressure cuff and EarlySense Vitals Surveillance System at the National Teaching Institute & Critical Care Exposition this week at the Boston Convention & Exhibition Center in Boston, Mass.
Given Imaging Announces New Data Confirming SmartPill Improves Diagnosis and Clinical Management of Patients With Motility Issues
May 20, 2013 11:02 am | by Globe Newswire | CommentsGiven Imaging Ltd, a world leader in GI medical devices and pioneer of capsule endoscopy, has announced several studies confirming an expanded role for SmartPill in diagnosing gastrointestinal motility disorders. All data were presented at Digestive Disease Week taking place May 18 - 21, 2013 at the Orange County Convention Center, Orlando, FL where Given Imaging is exhibiting at booth #1059 throughout the conference.
Biosensors Receives CE Mark Approval for BioMatrix NeoFlex
May 20, 2013 10:54 am | by Biosensors International | CommentsBioMatrix NeoFlex features a new advanced stent delivery system, improving pushability, trackability, and crossability. It also has a lower lesion entry profile than its predecessor. BioMatrix NeoFlex retains the same combination of abluminal biodegradable polymer coating, proprietary limus drug Biolimus A9, and platform that has made the BioMatrix stent family an increasingly popular choice of DES in global markets where available.
EDAP's Ablatherm-HIFU Demonstrates Long Term Efficacy, Durability and Reproducibility With Prospective Fourteen -Year Study
May 20, 2013 10:46 am | by GlobeNewswire | CommentsEDAP TMS SA, the global leader in therapeutic ultrasound, announced today new long term data demonstrating high rates of both cancer-specific and overall survival of patients treated with high-intensity focused ultrasound. The study led by Drs. Sebastien Crouzet and Albert Gelet of Edouard Herriot Hospital, located in Lyon, France evaluated the morbidity and long term oncologic outcomes of primary HIFU therapy for localized prostate cancer.
CardioDx Announces Publication of the IMPACT-CARD Trial Demonstrating Use of Corus@ CAD Test Influenced Cardiologists' Clinical Management of Patients with Symptoms Suggestive of Obstructive Coronary Artery Disease
May 20, 2013 8:31 am | by The Associated Press | CommentsCardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced the publication of the IMPACT-CARD (Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern) trial in Critical Pathways in Cardiology. This prospective...
